Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Critical Reviews in Oncology/Hematology
|
March 15, 2024
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications
Anna Amela Valsecchi, Giorgia Ferrari, Chiara Paratore, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
Giacomo Aimar, Chiara Paratore, Clizia Zichi, et al.
BMC Medicine
|
July 3, 2023
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes
Alberto Servetto, Massimo Di Maio, Fabio Salomone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2021
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review
Clizia Zichi, Chiara Paratore, Piera Gargiulo, et al.
BMJ Oncology
|
January 31, 2025
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study
Laura Marandino, Federica Trastu, Eleonora Ghisoni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2023
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study
Alessandro Rossi, Giacomo Aimar, Marco Audisio, et al.
Critical Reviews in Oncology/Hematology
|
February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
Marco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Cells
|
October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
Annapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.
Applied Clinical Informatics
|
September 11, 2024
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers
Carlos Berenguer Albiñana, Matteo Pallocca, Hayley Fenton, et al.
Cancer Medicine
|
January 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants
Michele Milella, Giulia Orsi, Mariacristina di Marco, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Critical Reviews in Oncology/Hematology
|
March 15, 2024
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications
Anna Amela Valsecchi, Giorgia Ferrari, Chiara Paratore, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
Giacomo Aimar, Chiara Paratore, Clizia Zichi, et al.
BMC Medicine
|
July 3, 2023
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes
Alberto Servetto, Massimo Di Maio, Fabio Salomone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2021
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review
Clizia Zichi, Chiara Paratore, Piera Gargiulo, et al.
BMJ Oncology
|
January 31, 2025
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study
Laura Marandino, Federica Trastu, Eleonora Ghisoni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2023
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study
Alessandro Rossi, Giacomo Aimar, Marco Audisio, et al.
Critical Reviews in Oncology/Hematology
|
February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
Marco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Cells
|
October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
Annapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.
Applied Clinical Informatics
|
September 11, 2024
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers
Carlos Berenguer Albiñana, Matteo Pallocca, Hayley Fenton, et al.
Cancer Medicine
|
January 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants
Michele Milella, Giulia Orsi, Mariacristina di Marco, et al.
Page
of 2